{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:27:51Z","timestamp":1782534471940,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"\u00a8NERKADAR\u00a8 foundation in Department of Nephrology, Hypertension and Internal Medicine in Bydgoszcz, Poland"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11255-017-1655-2","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T15:23:29Z","timestamp":1500045809000},"page":"1867-1873","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients"],"prefix":"10.1007","volume":"49","author":[{"given":"Rafa\u0142","family":"Donderski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Str\u00f3\u017cecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Sulikowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Grajewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Mi\u015bkowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Stefa\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Si\u00f3dmiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u017cyna","family":"Odrow\u0105\u017c-Sypniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Manitius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"issue":"1\u20133","key":"1655_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000441262","volume":"41","author":"AS Bomback","year":"2016","unstructured":"Bomback AS (2016) Mineralocorticoid receptor antagonists in end-stage renal disease: efficacy and safety. Blood Purif 41(1\u20133):166\u2013170. doi: 10.1159\/000441262","journal-title":"Blood Purif"},{"issue":"1\u20132","key":"1655_CR2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2003.10.009","volume":"217","author":"B Pitt","year":"2004","unstructured":"Pitt B (2004) Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies. Mol Cell Endocrinol 217(1\u20132):53\u201358 (Review)","journal-title":"Mol Cell Endocrinol"},{"key":"1655_CR3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.CIR.0000155621.10213.06","volume":"111","author":"VS Chhokar","year":"2005","unstructured":"Chhokar VS, Sun Y, Bhattacharya SK (2005) Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 111:871\u2013878","journal-title":"Circulation"},{"key":"1655_CR4","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/ndt\/gfg388","volume":"18","author":"P Saudan","year":"2003","unstructured":"Saudan P, Mach F, Perneger T, Schnetzler B, Stoermann C, Fumeaux Z, Rossier M, Martin P-Y (2003) Safety of low-dose spironolactone administration in chronic haemodialysis patients. Nephrol Dial Transplant 18:2359\u20132363","journal-title":"Nephrol Dial Transplant"},{"key":"1655_CR5","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jacc.2013.09.056","volume":"63","author":"Y Matsumoto","year":"2014","unstructured":"Matsumoto Y, Mori Y, Kageyama S, Arichara K, Sugiyama T, Ohmura H, Yakushigawa T, Sugiyama H, Shimada Y, Nojima Y, Shio N (2014) Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients. J Am Coll Cardiol 63:528\u2013536","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"1655_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10157-016-1363-8","volume":"21","author":"H Fujii","year":"2017","unstructured":"Fujii H, Joki N (2017) Mineral metabolism and cardiovascular disease in CKD. Clin Exp Nephrol 21(Suppl 1):53\u201363. doi: 10.1007\/s10157-016-1363-8","journal-title":"Clin Exp Nephrol"},{"key":"1655_CR7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/HJH.0b013e32835f955c","volume":"31","author":"P Flevaria","year":"2013","unstructured":"Flevaria P, Kalogeropouloub S, Drakoub A, Leftheriotisa D, Panoua F, Lekakisa J, Kremastinosa D, Vlahakosb DV (2013) Spironolactone improves endothelial and cardiac autonomic function in non heart failure hemodialysis patients. J Hypertens 31:1239\u20131244","journal-title":"J Hypertens"},{"issue":"154","key":"1655_CR8","first-page":"286","volume":"26","author":"K Fornalczyk","year":"2009","unstructured":"Fornalczyk K, Musia\u0142 K, Szczepa\u0144ska M, Zwoli\u0144ska D (2009) Osteopontin, platelet-derived growth factor and bone morphogenic protein-7 in children with chronic kidney disease on renal replacement therapy\u2014preliminary results. Pol Merkur Lekarski 26(154):286\u2013289","journal-title":"Pol Merkur Lekarski"},{"issue":"4","key":"1655_CR9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.20452\/pamw.1678","volume":"123","author":"K Janda","year":"2013","unstructured":"Janda K, Krzanowski M, Chowaniec E, Ku\u015bnierz-Cabala B, Dumnicka P, Kra\u015bniak A, Podolec P, Su\u0142owicz W (2013) Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis. Pol Arch Med Wewn 123(4):149\u2013155","journal-title":"Pol Arch Med Wewn"},{"issue":"7","key":"1655_CR10","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/ndt\/17.7.1293","volume":"17","author":"Y Nakazuto","year":"2002","unstructured":"Nakazuto Y, Yamaji Y, Oshima N, Havashi M, Saruta T (2002) Calcification and osteopontin localization in the peritoneum of patients on long-term continuous ambulatory peritoneal dialysis therapy. Nephrol Dial Transplant 17(7):1293\u20131303","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"1655_CR11","first-page":"1241","volume":"69","author":"K Janda","year":"2012","unstructured":"Janda K, Krzanowski M, Dumnicka P, Ku\u015bnierz-Cabala B, Su\u0142owicz W (2012) The relationship between advancement of secondary hyperparathyroidism and selected calcification parameters in peritoneal dialysis patients. Przegl Lek 69(12):1241\u20131245","journal-title":"Przegl Lek"},{"issue":"3","key":"1655_CR12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbrc.2014.03.149","volume":"447","author":"T Fumoto","year":"2014","unstructured":"Fumoto T, Ishii KA, Ito M, Berger S, Schutz G, Ikeda K (2014) Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia. Biochem Biophys Res Commun 447(3):407\u2013412","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"1655_CR13","doi-asserted-by":"crossref","first-page":"F967","DOI":"10.1152\/ajprenal.00669.2014","volume":"309","author":"N Tatsumoto","year":"2015","unstructured":"Tatsumoto N, Yamada S, Tokumoto M, Eriguchi M, Noguchi H, Torisu K, Tsuruya K, Kitazono T (2015) Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification. Am J Physiol Renal Physiol 309(11):F967\u2013F979","journal-title":"Am J Physiol Renal Physiol"},{"key":"1655_CR14","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/ndt\/gft409","volume":"29","author":"F Hammer","year":"2014","unstructured":"Hammer F, Krane V, St\u00f6rk S, R\u00f6ser C, Hofmann K, Pollak N, Allolio B, Wanner C (2014) Rationale and design of the mineralocorticoid receptor antagonists in end-stage renal disease study (MiREnDa). Nephrol Dial Transplant 29:400\u2013405","journal-title":"Nephrol Dial Transplant"},{"key":"1655_CR15","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1681\/ASN.2013030273","volume":"25","author":"Y Ito","year":"2014","unstructured":"Ito Y, Mizuno M, Suzuki Y, Tamai H, Hiramatsu T, Ohashi H, Ito I, Kasuga H, Horie M, Maruyama S, Yuzawa Y, Matsubara T, Matsuo S (2014) on behalf of the nagoya spiro study group: long-term effects of spironolactone in peritoneal dialysis patients. J Am Soc Nephrol 25:1094\u20131102","journal-title":"J Am Soc Nephrol"},{"key":"1655_CR16","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/ndt\/17.11.2035","volume":"17","author":"MJ Hausmann","year":"2002","unstructured":"Hausmann MJ, Liel-Cohen N (2002) Aldactone therapy in a peritoneal dialysis patient with decreased left ventricular function. Nephrol Dial Transplant 17:2035\u20132036","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1655_CR17","first-page":"507","volume":"23","author":"S Taheri","year":"2012","unstructured":"Taheri S, Mortazavi M, Pourmoghadas A, Seyrafian S, Alipour Z, Karimi S (2012) A prospective double-blind randomized placebo-controlled clinical trial to evaluate the safety and efficacy of spironolactone in patients with advanced congestive heart failure on continuous ambulatory peritoneal dialysis. Saudi J Kidney Dis Transpl 23(3):507\u2013512","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"3","key":"1655_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2478\/s1536-010-0014-9","volume":"5","author":"P Str\u00f3\u017cecki","year":"2010","unstructured":"Str\u00f3\u017cecki P, Donderski R, Grajewska M, Marcinkowska E, Koz\u0142owski M, Pollak J, Odrow\u0105\u017c-Sypniewska G, Manitius J (2010) Factors associated with increased pulse wave velocity in peritoneal dialysis patients. Cent Eur J Med 5(3)381\u2013386. doi: 10.2478\/s1536-010-0014-9","journal-title":"Cent Eur J Med"},{"key":"1655_CR19","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2215\/CJN.09421209","volume":"5","author":"A Vukusich","year":"2010","unstructured":"Vukusich A, Kunstmann S, Varela C, Gainza D, Bravo S, Sepulveda D, Cavada G, Michea L, Marusic ET (2010) A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients. Clin J Am Soc Nephrol 5:1380\u20131387","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1655_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/ndt\/gfn421","volume":"24","author":"I Kolesnyk","year":"2009","unstructured":"Kolesnyk I, Noordzij M, Dekker FW, Boeschoten EW, Krediet RT (2009) A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients. Nephrol Dial Transplant 24(1):272\u2013277. doi: 10.1093\/ndt\/gfn421","journal-title":"Nephrol Dial Transplant"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-017-1655-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1655-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1655-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T21:38:23Z","timestamp":1750628303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-017-1655-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1655"],"URL":"https:\/\/doi.org\/10.1007\/s11255-017-1655-2","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,14]]}}}